Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HEK-sGC |
Human embryonic kidney cell line, stably expressing human sGC (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | S. Meurer et al., Circ. Res., Jul 2009; 105: 33 - 41 | Link | |||
HEK RXFP2 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., J. Pharmacol. Exp. Ther., Jan 2007; 320: 281 - 290 | Link | |||
HEK RXFP2 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., Mol. Pharmacol., Jul 2006; 70: 214 - 226. | Link | |||
HEK RXFP1 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., Mol. Pharmacol., Jul 2006; 70: 214 - 226. | Link | |||
HEK RXFP1 |
Human embryonic kidney cell line, stably expressing RXFP1 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | M. L. Halls et al., J. Pharmacol. Exp. Ther., Jan 2007; 320: 281 - 290 | Link | |||
GP2-293 |
HEK 293-based retroviral packaging cell line | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | K. Hasse, Dissertation, 2012, Freie Universität Berlin | Link | ||
GP2-293 |
Human embrionic kidney retroviral packaging cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | J. Lausen et al., J. Biol. Chem., Feb 2010; 285: 5338 - 5346 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (Derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | B. K. Shrestha et al., J. Biol. Chem., 2019,doi/10.1074/jbc.RA119.010068 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | B.K. Shrestha et al., J Biol Chem., 2020, 295(5): 1240–1260, doi: 10.1074/jbc.RA119.010068 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | CRISPR | Metafectene PRO | publication | T. M. Nthiga et al., The EMBO J., 39: e103649, DOI 10.15252/embj.2019103649 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (Derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | J. Wright et al., J. Biol. Chem., Oct 2013; 288: 31010 - 31018 | Link | |||
Flp-in TREx 293 |
Human embryonic kidney cell line (Derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | T. Ramming, Dissertation, 2014, Universitaet Basel | Link | |||
Flp-in TREx 293 |
Human embryonic kidney cell line (Derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | J. J. Wright, PhD Thesis, 2015, University of Michigan | Link | |||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | T. M. Nthiga et al., The EMBO J., 39: e103649, DOI 10.15252/embj.2019103649 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | B.K. Shrestha et al., J Biol Chem., 2020, 295(5): 1240–1260, doi: 10.1074/jbc.RA119.010068 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (Derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | T. Ramming et al., Redox Biology, 2016, 714-20; doi.org/10.1016/j.redox.2015.11.004 | ||||
Flp-in TREx 293 |
Human embryonic kidney cell line (Derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | J. Birk et al., J. Cell Sci., Apr 2013; 126: 1604 - 1617 | Link | |||
Flp-In 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. M. Hoser et al., Genome Biology, 2020, 21: 299, doi.org/10.1186/s13059-020-02199-6 | Link | ||
EJ138 |
Human bladder carcinoma cell line | ECACC 85061108 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M.C. Burger et al., Int. J. of Oncology, 2012, 41: 235-241, DOI: 10.3892/ijo.2012.1446 | Link | |
ECV-304 |
Human uroepithelial bladder carcinoma cell line | DSM ACC 310 | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | J. Pelisek et al., J Mol Med (Berl), Nov 2002; 80(11): 724-36 | |||
ECV-304 |
Human uroepithelial bladder carcinoma cell line | DSM ACC 310 | Human | urinary system | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
CRFK |
Crandell feline kidney cells | ATCC CCL-94 | Cat | urinary system | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
COS-7 (s) |
African green monkey kidney fibroblast-like cell line (suspension) | ATCC CRL-1651 | Monkey | urinary system | cell line | suspension | plasmid | Metafectene PRO | application note | ![]() |
|||
COS-7 |
African green monkey kidney fibroblast-like cell line | ATCC CRL-1651 | Monkey | urinary system | cell line | adherent | plasmid | Metafectene | publication | C. L. Piechowski et al., J. Mol. Endocrinol., Jun 2013; 51: 109 - 118 | Link | ||
COS-7 |
African green monkey kidney fibroblast-like cell line | ATCC CRL-1651 | Monkey | urinary system | cell line | adherent | plasmid | Metafectene | publication | P. Hehlert, 2016, Dissertation, Georg-August-Universität Göttingen | Link |